These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36967388)

  • 1. The acceptability of overdose alert and response technologies: introducing the TPOM-ODART framework.
    Dumbrell J; Daneshvar H; Oteo A; Baldacchino A; Matheson C
    Harm Reduct J; 2023 Mar; 20(1):40. PubMed ID: 36967388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What impacts the acceptability of wearable devices that detect opioid overdose in people who use opioids? A qualitative study.
    Tas B; Walker H; Lawn W; Matcham F; Traykova EV; Evans RAS; Strang J
    Drug Alcohol Rev; 2024 Jan; 43(1):213-225. PubMed ID: 37596977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buprenorphine and naloxone access in pharmacies within high overdose areas of Los Angeles during the COVID-19 pandemic.
    Dadiomov D; Bolshakova M; Mikhaeilyan M; Trotzky-Sirr R
    Harm Reduct J; 2022 Jun; 19(1):69. PubMed ID: 35768817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized clinical trial of the effects of brief versus extended opioid overdose education on naloxone utilization outcomes by individuals with opioid use disorder.
    Jones JD; Campbell AN; Brandt L; Metz VE; Martinez S; Wall M; Corbeil T; Andrews H; Castillo F; Neale J; Strang J; Ross S; Comer SD
    Drug Alcohol Depend; 2022 Aug; 237():109505. PubMed ID: 35709575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Take-Home Naloxone Kits: Attitudes and Likelihood-Of-Use Outcomes from a European Survey of Potential Overdose Witnesses.
    McDonald R; Breidahl S; Abel-Ollo K; Akhtar S; Clausen T; Day E; Kelleher M; McAuley A; Petersen H; Sefranek M; Thiesen H; Strang J
    Eur Addict Res; 2022; 28(3):220-225. PubMed ID: 35114666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "I don't go to funerals anymore": how people who use opioids grieve drug-related death in the US overdose epidemic.
    Schlosser AV; Hoffer LD
    Harm Reduct J; 2022 Oct; 19(1):110. PubMed ID: 36183109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in overdose experiences and prevention behaviors among people who use opioids in Baltimore, MD, 2017-2019.
    Dayton L; Mazhnaya A; Schneider KE; Kong X; Winiker A; Davey-Rothwell M; Tobin KE; Latkin CA
    Drug Alcohol Depend; 2021 Apr; 221():108650. PubMed ID: 33684772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "They're not doing enough.": women's experiences with opioids and naloxone in Toronto.
    Macleod ER; Tajbakhsh I; Hamilton-Wright S; Laliberte N; Wiese JL; Matheson FI
    Subst Abuse Treat Prev Policy; 2021 Mar; 16(1):26. PubMed ID: 33743756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage study.
    Conway A; Valerio H; Peacock A; Degenhardt L; Hayllar J; Harrod ME; Henderson C; Read P; Gilliver R; Christmass M; Dunlop A; Montebello M; Whitton G; Reid D; Lam T; Alavi M; Silk D; Marshall AD; Treloar C; Dore GJ; Grebely J;
    Int J Drug Policy; 2021 Oct; 96():103421. PubMed ID: 34452808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality risk and causes of death among people who use opioids in a take-home naloxone cohort.
    Ericson ØB; Eide D; Lobmaier P; Clausen T
    Drug Alcohol Depend; 2024 Feb; 255():111087. PubMed ID: 38228056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized controlled trial of a computerized opioid overdose education intervention.
    Dunn KE; Yepez-Laubach C; Nuzzo PA; Fingerhood M; Kelly A; Berman S; Bigelow GE
    Drug Alcohol Depend; 2017 Apr; 173 Suppl 1(Suppl 1):S39-S47. PubMed ID: 28363318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practical implications of naloxone knowledge among suburban people who use opioids.
    Schneider KE; Urquhart GJ; Rouhani S; Park JN; Morris M; Allen ST; Sherman SG
    Harm Reduct J; 2021 Apr; 18(1):47. PubMed ID: 33910565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overdose Alert and Response Technologies: State-of-the-art Review.
    Oteo A; Daneshvar H; Baldacchino A; Matheson C
    J Med Internet Res; 2023 Feb; 25():e40389. PubMed ID: 36790860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sweden's first Take-Home Naloxone program: participant characteristics, dose endpoints and predictors for overdose reversals.
    Holmén E; Warnqvist A; Kåberg M
    Subst Abuse Treat Prev Policy; 2023 Apr; 18(1):24. PubMed ID: 37087485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personal experience and awareness of opioid overdose occurrence among peers and willingness to administer naloxone in South Africa: findings from a three-city pilot survey of homeless people who use drugs.
    Wilson M; Brumwell A; Stowe MJ; Shelly S; Scheibe A
    Harm Reduct J; 2022 Feb; 19(1):17. PubMed ID: 35148779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overdose Education and Naloxone for Patients Prescribed Opioids in Primary Care: A Qualitative Study of Primary Care Staff.
    Binswanger IA; Koester S; Mueller SR; Gardner EM; Goddard K; Glanz JM
    J Gen Intern Med; 2015 Dec; 30(12):1837-44. PubMed ID: 26055224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and implementability of state-level naloxone access policies: Expert consensus from an online modified-Delphi process.
    Smart R; Grant S
    Int J Drug Policy; 2021 Dec; 98():103383. PubMed ID: 34340167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naloxone protection, social support, network characteristics, and overdose experiences among a cohort of people who use illicit opioids in New York City.
    Bennett AS; Scheidell J; Bowles JM; Khan M; Roth A; Hoff L; Marini C; Elliott L
    Harm Reduct J; 2022 Mar; 19(1):20. PubMed ID: 35246165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community perspectives on supervised consumption sites: Insights from four U.S. counties deeply affected by opioids.
    Taylor J; Ober AJ; Kilmer B; Caulkins JP; Iguchi MY
    J Subst Abuse Treat; 2021 Dec; 131():108397. PubMed ID: 34098293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twenty years of take-home naloxone for the prevention of overdose deaths from heroin and other opioids-Conception and maturation.
    McDonald R; Campbell ND; Strang J
    Drug Alcohol Depend; 2017 Sep; 178():176-187. PubMed ID: 28654870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.